Analysts' Actions: FB, ONXX, RHT, UA, V

NEW YORK (TheStreet) -- CHANGE IN RATINGS

AO Smith (AOS) rated new Market Perform at BMO. $55 price target. Company is seeing slower domestic growth.

Brookfield Infrastructure Partners (BIP) rated new Neutral at Citigroup. $34 price target. Fully valued at current levels despite risk averse business model.

Centerpoint (CNP) downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. Valuation call, based on a $21 price target.

CIFC (DFR) downgraded to sell at TheStreet Ratings.

Facebook (FB) rated new Hold at Argus. Still uncertain how the company will monetize growth in mobile access.

Intercontinental Exchange (ICE) rated new Hold at BGB Securities. $145 price target. Lower commodity prices and volatility could weigh on volumes.

Laboratory Corp. of America (LH) rated new Buy at Canaccord. $100 price target. Company is a low-cost provider and volumes have likely troughed.

NII (NIHD) downgraded at Wells to Market Perform, Wells Fargo said. Estimates also cut, as the dollar remains an earnings headwind.

New Mountain Finance (NMFC) initiated as hold at TheStreet Ratings.

Onyx Pharmaceuticals (ONXX) rated new Buy at Deutsche. $58 price target. Kyprolis should be the company's next main growth driver.

Onyx Pharmaceuticals upgraded at Brean Murray from Hold to Buy. $60 price target. New cancer drug should be approved by the FDA next month.

TJX Companies (TJX) upgraded at Wells from Market Perform to Outperform, Wells Fargo said. Company is likely gaining market share from JCP, which could help boost sales growth.

Under Armour (UA) downgraded at UBS to Neutral from Buy, UBS said. $105 price target. Stock run, high valuation, diminishing outperformance.

Woodward (WWD) rated new Outperform at Credit Suisse. $48 price target. Company has strong market positioning and can deliver consistent organic growth.